T-Up/Astec Biologics criminal charges
This article was originally published in The Tan Sheet
Executive Summary
Firms' President Allen Hoffman sentenced Nov. 30 to 46 months in federal prison, ordered to pay $222,506 restitution after pleading guilty to two counts of introducing unapproved new drug (aloe vera compounds) into interstate commerce with intent to defraud. A Baltimore federal jury had deadlocked on all but one charge against Hoffman and T-Up in a June 2000 trial (1"The Tan Sheet" July 3, 2000, In Brief). Hoffman marketed products as treatments for cancer, other diseases...
You may also be interested in...
T-Up, Inc.
Baltimore firm and its principals are appealing a $3.7 mil. fine by the Maryland Attorney General for making claims their aloe vera and mineral health products cure diseases such as cancer and AIDS. T-Up products were marketed for oral consumption or IV administration without FDA approval and lacked adequate safety and efficacy data, the AG asserted. T-Up, President Allen Hoffman and two others were indicted in July 1999 on federal charges of conspiracy, mail and wire fraud and introducing an unapproved new drug into commerce. A Baltimore federal jury on June 15 deadlocked on all but one charge against the firm and Hoffman, finding them not guilty on one mail fraud count. The jury found an Oklahoma supplier of the products not guilty on all counts
Israel's Gamida Cell Survives By Selling To Lender
Having finally secured US approval for Omisirge, Gamida was hoping to bag a strategic partner for the cell therapy. A year on, no suitable partner has been identified and the firm is delisting from the NASDAQ and going private.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.